Crinetics Pharmaceuticals (CRNX) Enterprise Value Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.35% |
| Dec 31, 2025 | 24.09% |
| Sep 30, 2025 | -26.62% |
| Jun 30, 2025 | -39.12% |
| Mar 31, 2025 | -41.42% |
| Dec 31, 2024 | -142.42% |
| Sep 30, 2024 | -504.13% |
| Jun 30, 2024 | -2,045.53% |
| Mar 31, 2024 | -2,052.27% |
| Dec 31, 2023 | -1,512.41% |
| Sep 30, 2023 | 61.24% |
| Jun 30, 2023 | 35.54% |
| Mar 31, 2023 | 86.91% |
| Dec 31, 2022 | 82.79% |
| Sep 30, 2022 | -90.54% |
| Jun 30, 2022 | 69.38% |
| Mar 31, 2022 | -112.21% |
| Dec 31, 2021 | -17.78% |
| Sep 30, 2021 | -3.48% |
| Jun 30, 2021 | 0.68% |
| Mar 31, 2021 | -33.57% |
| Dec 31, 2020 | -44.33% |
| Sep 30, 2020 | -41.88% |
| Jun 30, 2020 | 10.90% |
| Mar 31, 2020 | 28.25% |
| Dec 31, 2019 | 27.75% |
| Sep 30, 2019 | 22.39% |
| Jun 30, 2019 | -236.60% |
| Dec 31, 2018 | -1,054.70% |